PARIS (Reuters) : French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence.
Sanofi said in a statement that the partnership with OpenAI will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources.
Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.
F.P. Report ISLAMABAD: China’s Minister of Central Committee of the International Department of Communist Party…
F.P. Report ISLAMABAD: Prime Minister Muhammad Shehbaz Sharif on Friday said the country's economic growth…
F.P. Report KARACHI: Key partner in the incumbent government, Pakistan Peoples Party (PPP) Chairman Bilawal…
F.P. Report RAWALPINDI: An improvised explosive device exploded on a vehicle of Security Forces in…
F.P. Report PESHAWAR: Khyber Pakhtunkhwa Chief Minister Ali Amin Gandapur has once again threatened the…
F.P. Report ISLAMABAD: The National Assembly on Friday echoed with strong calls directed at the…
This website uses cookies.